Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Unison Pharmaceuticals
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Peers
Registered Details

Get this company's details upto March 2024. FREE access. Sign up now!

UNISON PHARMACEUTICALS PRIVATE LIMITED

www.unisonpharmaceuticals.com

All Companies ›

Gujarat ›

Manufacturing of Chemical Products ›

UNISON PHARMACEUTICALS PRIVATE LIMITED

Active

Updated: 19 Apr 2025

Unison Pharmaceuticals Private Limited, is an unlisted private company incorporated on 01 June, 2001. It is classified as a private limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 9.00 cr.

Unison Pharmaceuticals's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 39.75% over the previous year. At the same time, it's book networth has increased by 20.84%.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

Cardiovascular Medical Treatment Services, Pain Management, Anti Allergics, Anti Ulcerents and Anxiolytics., Anti Diabetics

Company size

Auth Capital

₹ 10.0 Cr

Paidup Capital

₹ 9.0 Cr

Revenue

₹ 500-500 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

29.61%

₹ GET PRO

EBITDA

55.87%

₹ GET PRO

Net Profit

87.16%

₹ GET PRO

Networth

32.27%

₹ GET PRO

Borrowings

-10.45%

₹ GET PRO

Assets

28.18%

₹ GET PRO

Gross Margin

0.21

GET PRO %

Operating Margin

3.94

GET PRO %

Net Profit Margin

4.38

GET PRO %

Return on Equity

7.16

GET PRO %

ROCE

8.6

GET PRO %

Debt to Equity

-0.01

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (20)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Nitin Rasiklal Shah Shareholder	02287767	12 years
Managing Director	Bhagyesh Nitinbhai Shah Shareholder	02287794	12 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	4.5	9.0	9.0	9.0	9.0
Reserves	116.9	131.9	151.3	184.7	247.3
Borrowings +	38.3	34.3	15.9	8.4	7.5
Long term borrowings	23.6	23.2	2.8	2.4	2.4
Short term borrowings	14.7	11.1	13.1	6.0	5.1
Trade payables +	15.4	12.7	19.3	27.6	30.2
Days payable	86.0	67.0	69.0	88.0	75.0
Other liabilities +	25.6	25.7	31.2	39.4	45.8
Other non-current liabilities	4.5	5.8	5.1	3.9	5.2
Other current liabilities	5.7	7.3	6.8	8.0	10.4
Total liabilities	185.3	200.9	207.4	241.5	309.6
Fixed Assets +	132.4	128.1	120.4	107.8	145.2
Tangible assets	116.7	115.8	109.2	103.3	135.3
CWIP	-	0.4	3.3	-	9.5
Intangible assets	15.7	11.8	7.9	4.5	0.4
LT loans and advances	0.2	0.4	-	-	-
Other non-current assets	-	-	0.6	0.6	1.6
Current assets +	52.7	72.5	86.5	133.1	162.7
Inventories	30.0	45.1	45.4	70.3	79.0
Trade receivables	15.5	17.5	14.9	25.2	30.5
Cash and cash equivalents	3.3	6.3	21.5	32.6	46.9
ST loans and advances	4.0	2.6	3.1	3.0	3.1
Other current assets	-	1.0	1.6	2.0	3.2
Total assets	185.3	200.9	207.4	241.5	309.6

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	2.43	4.48	4.34	3.73	2.91
Reserves	63.07	65.62	72.95	76.49	79.87
Borrowings +	20.67	17.08	7.67	3.46	2.42
Long term borrowings	12.75	11.56	1.37	0.97	0.76
Short term borrowings	7.92	5.53	6.29	2.49	1.65
Trade payables	8.33	6.32	9.31	11.41	9.77
Other liabilities +	13.83	12.81	15.04	16.32	14.8
Other non-current liabilities	2.42	2.87	2.47	1.61	1.68
Other current liabilities	3.07	3.63	3.26	3.3	3.36
Total liabilities
Fixed Assets +	71.45	63.73	58.04	44.65	46.9
Tangible assets	62.97	57.65	52.66	42.77	43.71
CWIP	0.0	0.21	1.59	0.0	3.06
Intangible assets	8.49	5.87	3.79	1.88	0.13
LT loans and advances	0.13	0.19	0.0	0.0	0.0
Other non-current assets	0.0	0.0	0.27	0.24	0.53
Current assets +	28.42	36.07	41.69	55.11	52.57
Inventories	16.16	22.43	21.91	29.12	25.52
Trade receivables	8.37	8.71	7.16	10.44	9.84
Cash and cash equivalents	1.76	3.13	10.36	13.49	15.16
ST loans and advances	2.13	1.31	1.48	1.23	1.01
Other current assets	0.0	0.5	0.78	0.83	1.03
Total assets

Total assets

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 3

Total Amount : 70.3 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	35.0 cr	17 Oct, 2023
HDFC Bank Limited	35.0 cr	17 Oct, 2023
HDFC Bank Limited	0.3 cr	27 Aug, 2020

Charges

HDFC Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
UNISON REMEDIES PRIVATE LIMITED	Active	1.0 L	2	Gujarat
UNISON LIFE SCIENCES PRIVATE LIMITED	Active	1.0 L	2	Gujarat
UNISON BIOSCIENCE PRIVATE LIMITED	Active	1.0 L	2	Gujarat
UNISON RESEARCH PRIVATE LIMITED	Active	1.0 L	2	Gujarat
UNISON NUTRACEUTICALS PRIVATE LIMITED	Active	1.0 L	2	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
UNISON REMEDIES PRIVATE LIMITED	Gujarat	2012	₹ 1.0 L
Unison Pharmaceuticals(UK) Limited	United Kingdom	-	-

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Acme Formulation Private Limited Himachal Pradesh

Milan Laboratories (India) Private Limited Maharashtra

Tirupati Medicare Limited Delhi

Smart Laboratories Private Limited Gujarat

Peers

Acme Formulation Private Limited

Himachal Pradesh

Milan Laboratories (India) Private Limited

Maharashtra

Tirupati Medicare Limited

Delhi

Smart Laboratories Private Limited

Gujarat

Registered Details

CIN

U24232GJ2001PTC079092

PAN

AABCU6937A

Incorporation

2001, 24.1 years

Company Email

unisonpharmaceuticals@yahoo.com

Paid up Capital

₹ 9.0 Cr

Authorised Capital

₹ 10.0 Cr

AGM

Sep 2023

Type

Private

Non-government Company

FAQ - UNISON PHARMACEUTICALS PRIVATE LIMITED

What is the incorporation date of UNISON PHARMACEUTICALS PRIVATE LIMITED?

The incorporation date of UNISON PHARMACEUTICALS PRIVATE LIMITED is 01 June, 2001

What is the authorized share capital of UNISON PHARMACEUTICALS PRIVATE LIMITED?

The authorized share capital of UNISON PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 10.0 Cr.

What is the paid-up capital of UNISON PHARMACEUTICALS PRIVATE LIMITED?

The paid-up capital of UNISON PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 9.0 Cr.

What is the registered address of UNISON PHARMACEUTICALS PRIVATE LIMITED?

The registered address of UNISON PHARMACEUTICALS PRIVATE LIMITED is Unison House, Nr. Prernatirth Derasar Nr. Ratnadeep-II, Satellite, Jodhpur Ahmedabad Ahmedabad Gujarat - 380015

What is the CIN number of UNISON PHARMACEUTICALS PRIVATE LIMITED?

The CIN number of UNISON PHARMACEUTICALS PRIVATE LIMITED is U24232GJ2001PTC079092.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

UNISON PHARMACEUTICALS PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network